NTU89

Caenorhabditis elegans

NTU94

Caenorhabditis elegans

rtEx723

Caenorhabditis elegans

[KS(+); che-2p::glp-1(IC); elt-2p::gfp]

MOS622

Caenorhabditis elegans

PS8408

Caenorhabditis elegans

MOS840

Caenorhabditis elegans

MOS839

Caenorhabditis elegans

algn-6

Caenorhabditis elegans

Predicted to enable dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity. Predicted to be involved in dolichol-linked oligosaccharide biosynthetic process. Predicted to be located in endoplasmic reticulum membrane. Human ortholog(s) of this gene implicated in congenital disorder of glycosylation Ic. Is an ortholog of human ALG6 (ALG6 alpha-1,3-glucosyltransferase).

C42C1.19

Caenorhabditis elegans

Predicted to enable glucose 6-phosphate:phosphate antiporter activity. Predicted to be involved in glucose-6-phosphate transport and phosphate ion transmembrane transport. Predicted to be located in endoplasmic reticulum membrane. Human ortholog(s) of this gene implicated in congenital disorder of glycosylation type II; glycogen storage disease Ib; and glycogen storage disease Ic. Is an ortholog of human SLC37A4 (solute carrier family 37 member 4).

F47B8.10

Caenorhabditis elegans

Predicted to enable glucose 6-phosphate:phosphate antiporter activity. Predicted to be involved in glucose-6-phosphate transport and phosphate ion transmembrane transport. Predicted to be located in endoplasmic reticulum membrane. Human ortholog(s) of this gene implicated in congenital disorder of glycosylation type II; glycogen storage disease Ib; and glycogen storage disease Ic. Is an ortholog of human SLC37A4 (solute carrier family 37 member 4).